Skip to content
  • Tuesday, 29 September 2026
  • 10:30 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Unlocking the Bone Marrow Microenvironment: How Chronic Inflammation Fuels Pre-Leukemic States and Age-Related Blood Cancers
Stem Cell & Regenerative Medicine

Unlocking the Bone Marrow Microenvironment: How Chronic Inflammation Fuels Pre-Leukemic States and Age-Related Blood Cancers

Dwi Wanna Sep 27, 2026 0

Every second of every day, the human bone marrow serves as a tireless biological factory, generating millions of fresh blood…

Read More
Advanced Materials Science

Transforming Plastic Waste Into High-Value Fuels: Breakthrough ORNL Molten Salt Method Yields Gasoline and Diesel at Low Temperatures

Nila Kartika Wati Sep 22, 2026 0

The global plastic waste crisis has long challenged environmental scientists, municipal waste managers, and energy policy experts alike. With millions…

Read More
Stem Cell & Regenerative Medicine

Decoding the Microenvironment: How Bone Marrow Inflammation Fuels Pre-Leukemic States and Blood Cancers

Dwi Wanna Sep 20, 2026 0

Every single second, the human bone marrow functions as a biological engine of staggering output, generating millions of fresh blood…

Read More
Stem Cell & Regenerative Medicine

Unlocking the Hidden Architecture of Blood Cancers: How Bone Marrow Inflammation Fuels Pre-Leukemic States and Aging

Dwi Wanna Sep 12, 2026 0

Every single second, the human bone marrow functions as a biological factory of astonishing scale, generating millions of fresh blood…

Read More
Pharmaceutical R&D

Novo Nordisk’s Wegovy Pill Fuels Ambitious Growth Strategy Amidst Fierce Competition

Teuku Ryan May 8, 2026 0

Novo Nordisk’s groundbreaking oral semaglutide medication, branded as Wegovy, has emerged as a powerful financial engine, propelling the Danish pharmaceutical…

Read More
Pharmaceutical R&D

The Surge in Oncology Innovation Fuels Strategic Investment in HPAPI and ADC Manufacturing Capabilities

Teuku Ryan Apr 30, 2026 0

The accelerating demand for highly potent active pharmaceutical ingredients (HPAPIs) and antibody-drug conjugates (ADCs) is compelling contract development and manufacturing…

Read More
New Research from University of Illinois Identifies Glycan-Based Method to Extend Sperm Viability and Improve IVF Success RatesUnlocking Deep Time: Ancient Regulatory DNA Reveals Secrets of Plant EvolutionBreakthrough in PFAS Degradation Scientists Identify Hydrogen Radicals as Key to Destroying Forever Chemicals Using UV LightScientists Uncover Potent Human Antibodies, Paving the Way for First-Ever Measles Treatment and Prevention
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research StudyMolten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low TemperaturesDaiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA DiscussionsScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research Study
Dwi Wanna Sep 29, 2026
Advanced Materials Science
Molten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low Temperatures
Nila Kartika Wati Sep 29, 2026
Pharmaceutical R&D
Daiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA Discussions
Teuku Ryan Sep 29, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ